Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 51 of 663 for:    SMS

Economic and Clinical Outcomes of Attendance in Psychosis Services Using SMS. (ECO APSS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01793220
Recruitment Status : Unknown
Verified February 2013 by Daniel Hayes, King's College London.
Recruitment status was:  Not yet recruiting
First Posted : February 15, 2013
Last Update Posted : February 15, 2013
Sponsor:
Information provided by (Responsible Party):
Daniel Hayes, King's College London

Brief Summary:
The aim of this research is to find out if mobile phone text message reminders of appointments can help to address missed appointments in Psychosis Community Services. Another aim is to examine if fewer missed appointments result in clinical benefits for service users and in lower costs for Psychosis Community Services over a period of 6 months. 600 users from 2 London Psychosis Community Services will take part in this research. Each participant will be put into one of two groups, as s/he joins the study: In the first (experimental) group, each participant will receive appointment reminders for 6 months (7 and 1 day/s before each appointment), starting with the first available opportunity upon joining the study. In the second (control) group, each participant will not receive appointment reminders for 6 months. The choice of group for each individual will be made at random by a computer. Clinical information will be collected for 6 months from the time each participant joins the study, using, with his or her consent, their anonymised electronic medical records. The following clinical information will be compared between the experimental and control groups: Attendance of appointments, number of inpatient admissions, number of days in inpatient care, number of inpatient admissions under the mental health treatment act, number of referrals to a home treatment team, number of times patient has changed medication, health and social functioning. Service use, service costs and the cost-effectiveness of the reminder system will also be examined. Towards the end of their participation, service users, as well as mental health professionals, will be invited to express their views, concerns and suggestions in relation to the reminder service by completing a brief anonymised (service users) or anonymous (staff) questionnaire

Condition or disease Intervention/treatment Phase
Psychosis Other: SMS reminder Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 600 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Economic and Clinical Outcomes of Attendance in Psychosis Services Using SMS: The ECO APSS Randomized Controlled Trial
Study Start Date : March 2013
Estimated Primary Completion Date : March 2015
Estimated Study Completion Date : March 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: SMS Reminder
A text message reminder service will be sent 7 and 1 days(s) prior to the patients appointment at their Psychosis Community Service.
Other: SMS reminder
A text message reminder service will be sent 7 and 1 days(s) prior to the patients appointment at their Psychosis Community Service.

No Intervention: No SMS Reminders
The service user will not be sent text message reminders prior to each appointment at their Psychosis Community Service



Primary Outcome Measures :
  1. Outcome of appointment (attended, missed, cancelled by the participant, cancelled by the service) [ Time Frame: From baseline to end of intervention (6 months) ]
    To assess differences in appointment attendance using online patient records in those who receive the SMS appointment reminders and those that do not


Secondary Outcome Measures :
  1. Economic outcome: Use of Psychosis Services and impact on cost [ Time Frame: From baseline to end of intervention (6 months) ]
    Data on the use of services over the follow-up period will be combined with appropriate unit cost information (Curtis, 2011; Department of health, 2012). Service costs will be compared between the experimental (SMS intervention) and control (No SMS intervention)groups. Cost data often follow a skewed distribution and so bootstrap methods will be employed

  2. Clinical outcome: Number of inpatient admissions [ Time Frame: From baseline to end of intervention (6 months) ]
    To assess differences in the number of inpatient admissions using online patient records in those who receive the SMS appointment reminders and those that do not

  3. Clinical outcome: Number of days in inpatient care [ Time Frame: From baseline to end of intervention (6 months) ]
    To assess differences in number of days in inpatient care using online patient records in those who receive the SMS appointment reminders and those that do not

  4. Clinical outcome: Number of inpatient admissions under the mental health treatment act [ Time Frame: From baseline to end of intervention (6 months) ]
    To assess differences in number of inpatient admissions under the mental health act using online patient records in those who receive the SMS appointment reminders and those that do not

  5. Clinical outcome: Number of referrals to a home treatment team [ Time Frame: From baseline to end of intervention (6 months) ]
    To assess differences in the number of times a patient has been referred to a home treatment team, using online patient records (a crisis team who further support those with declining mental health) in those who receive the SMS appointment reminders and those that do not

  6. Clinical outcome: Number of times patient has had changes to their medication [ Time Frame: From baseline to end of intervention (6 months) ]
    To assess differences in the number of times patient has had changes to their medication using online patient records in those who receive the SMS appointment reminders and those that do not

  7. Clinical outcome: Level of health and social functioning, as reflected in the patient's score on the Health of the Nation Outcome Scales (HoNOS) [ Time Frame: Baseline and 6 months ]
    To assess differences in levels of health and social functioning in those who receive the SMS appointment reminders and those that do not

  8. Economic outcome: cost effectiveness of the SMS intervention [ Time Frame: 1 year after baseline ]
    The cost of the actual intervention will be negligible given the extent of general SMS use. However, there could be an impact on service costs and this will be estimated. Data on the use of services over the follow-up period (see below for details) will be combined with appropriate unit cost information (Curtis, 2011; Department of health, 2012). Cost-effectiveness will be assessed by combining the cost data with HoNOS scores using an incremental cost-effectiveness ratio. Uncertainty around the cost-effectiveness estimates will be explored using cost-effectiveness planes and cost-effectiveness acceptability curves.


Other Outcome Measures:
  1. Views and suggestions of services users in relation to the SMS reminders [ Time Frame: 6 months (end of study participation) ]
    At the end of their participation, service users will be invited to complete an optional brief questionnaire (designed for the purposes of the study by the research team), to express their views, concerns and suggestions in relation to the SMS service. This information will be collected in an anonymised format. The questionnaires will be posted to the study participants, or alternatively, administered to them over the telephone or in person (whichever they prefer) by a research worker.

  2. Views and suggestions of mental health professionals in relation to the SMS reminders [ Time Frame: After the study has ended (1 year after 1st recruitment) ]
    At the end of ths study, staff from participating services will be invited to complete an optional brief questionnaire (designed for the purposes of the study by the research team), to express their views, concerns and suggestions in relation to the SMS service. This information will be collected in an anonymous format. The questionnaires will be given to staff and posted back to the researcher.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Be a user of Psychosis Community Services
  • Manifest at least a basic level of comprehension of the study (including its nature, purpose, procedures and implications) prior to enrollment, and adequate capacity to consent, as assessed by the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) scale.
  • Own a mobile phone.
  • Be willing to receive SMS reminders of appointments with the Psychosis Community Service.
  • Provide written informed consent to participate in the study.

Exclusion Criteria:

  • Is not a user of Psychosis Community Services.
  • Cannot manifest at least a basic level of comprehension of the study (including its nature, purpose, procedures and implications) prior to enrollment, and/or adequate capacity to consent, as assessed by the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) scale.
  • Does not own a mobile phone.
  • Is under 18 years of age.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01793220


Contacts
Layout table for location contacts
Contact: Daniel P Hayes, MSc +44 (0) 207 848 0357 daniel.1.hayes@kcl.ac.uk
Contact: Eugenia Kravariti, PhD +44 (0) 207 848 0331 eugenia.kravariti@kcl.ac.uk

Locations
Layout table for location information
United Kingdom
South London and Maudsley NHS Foundation Trust Not yet recruiting
London, Greater London, United Kingdom, BR3 3BX
Sponsors and Collaborators
King's College London
Investigators
Layout table for investigator information
Principal Investigator: Daniel P Hayes, MSc King's College London

Layout table for additonal information
Responsible Party: Daniel Hayes, Mr, King's College London
ClinicalTrials.gov Identifier: NCT01793220     History of Changes
Other Study ID Numbers: ECOAPSS1
First Posted: February 15, 2013    Key Record Dates
Last Update Posted: February 15, 2013
Last Verified: February 2013
Additional relevant MeSH terms:
Layout table for MeSH terms
Psychotic Disorders
Mental Disorders
Schizophrenia Spectrum and Other Psychotic Disorders